Matinas BioPharma Holdings Inc (MTNB) Reports Q3 2023 Financial Results and Business Progress
Key Developments and Financial Highlights for Investors
Stay updated with breaking news from Clinical Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Key Developments and Financial Highlights for Investors
The writings of the Covenant School shooter are disturbing and can bring back painful memories of that day. One mental health expert discusses how the writings can bring back painful memories.
Propel Bio Partners invests in companies that improve the quality of life for those with medical conditions, empowering startups with a patient-centric focus for market success.
PHILADELPHIA, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today announced that William Chou, M.D., president and chief executive officer, will participate in a fireside chat at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference on Monday, November 6, 2023 at 2:30 p.m. ET. A live webcast of the event will be available on
Coverage from The US Oncology Network Payer Transformation Summit, held September 27-29, 2023, in Atlanta, Georgia.